Abstract

Mitochondrial defects are implicated in multiple diseases and aging. Exercise training is an accessible, inexpensive therapeutic intervention that can improve mitochondrial bioenergetics and quality of life. By combining multiple omics techniques with biochemical and in silico normalisation, we removed the bias arising from the training-induced increase in mitochondrial content to unearth an intricate and previously undemonstrated network of differentially prioritised mitochondrial adaptations. We show that changes in hundreds of transcripts, proteins, and lipids are not stoichiometrically linked to the overall increase in mitochondrial content. Our findings suggest enhancing electron flow to oxidative phosphorylation (OXPHOS) is more important to improve ATP generation than increasing the abundance of the OXPHOS machinery, and do not support the hypothesis that training-induced supercomplex formation enhances mitochondrial bioenergetics. Our study provides an analytical approach allowing unbiased and in-depth investigations of training-induced mitochondrial adaptations, challenging our current understanding, and calling for careful reinterpretation of previous findings.

Exercise training can be therapeutic but how mitochondria respond remains unclear. Here, the authors use multiple omics techniques to reveal a complex network of non-stoichiometric mitochondrial adaptations that are prioritized or deprioritised during different phases of exercise training.

Details

Title
High-intensity training induces non-stoichiometric changes in the mitochondrial proteome of human skeletal muscle without reorganisation of respiratory chain content
Author
Granata Cesare 1   VIAFID ORCID Logo  ; Caruana, Nikeisha J 2   VIAFID ORCID Logo  ; Botella Javier 3   VIAFID ORCID Logo  ; Jamnick, Nicholas A 4 ; Huynh, Kevin 5   VIAFID ORCID Logo  ; Kuang Jujiao 3   VIAFID ORCID Logo  ; Janssen, Hans A 3 ; Reljic Boris 6   VIAFID ORCID Logo  ; Mellett, Natalie A 5 ; Laskowski, Adrienne 7 ; Stait Tegan L 8 ; Frazier, Ann E 9   VIAFID ORCID Logo  ; Coughlan, Melinda T 10   VIAFID ORCID Logo  ; Meikle, Peter J 5   VIAFID ORCID Logo  ; Thorburn, David R 11   VIAFID ORCID Logo  ; Stroud, David A 12   VIAFID ORCID Logo  ; Bishop, David J 3   VIAFID ORCID Logo 

 Victoria University, Institute for Health and Sport (iHeS), Melbourne, Australia (GRID:grid.1019.9) (ISNI:0000 0001 0396 9544); Monash University, Department of Diabetes, Central Clinical School, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Heinrich Heine University, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917) 
 Victoria University, Institute for Health and Sport (iHeS), Melbourne, Australia (GRID:grid.1019.9) (ISNI:0000 0001 0396 9544); The University of Melbourne, Department of Biochemistry and Pharmacology and Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Victoria University, Institute for Health and Sport (iHeS), Melbourne, Australia (GRID:grid.1019.9) (ISNI:0000 0001 0396 9544) 
 Victoria University, Institute for Health and Sport (iHeS), Melbourne, Australia (GRID:grid.1019.9) (ISNI:0000 0001 0396 9544); Deakin University, Metabolic Research Unit, School of Medicine and Institute for Mental and Physical Health and Clinical Translation (iMPACT), Geelong, Australia (GRID:grid.1021.2) (ISNI:0000 0001 0526 7079) 
 Baker Heart & Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620) 
 The University of Melbourne, Department of Biochemistry and Pharmacology and Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Monash University, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Monash University, Department of Diabetes, Central Clinical School, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Royal Children’s Hospital, Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346) 
 Royal Children’s Hospital, Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346); The University of Melbourne, Department of Paediatrics, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
10  Monash University, Department of Diabetes, Central Clinical School, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Baker Heart & Diabetes Institute, Melbourne, Australia (GRID:grid.1051.5) (ISNI:0000 0000 9760 5620) 
11  Royal Children’s Hospital, Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346); The University of Melbourne, Department of Paediatrics, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Royal Children’s Hospital, Victorian Clinical Genetics Services, Melbourne, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346) 
12  The University of Melbourne, Department of Biochemistry and Pharmacology and Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Royal Children’s Hospital, Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2605770290
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.